Asian Journal Of Social Pharmacy

Asian Journal of Social Pharmacy

20 March 2020, Volume 15 Issue 1 Previous Issue    Next Issue

Factors Influencing the Implementation of Drug Standards Improvement in China

Zhao Jianfeng, Zhang Wei, Yu Hai

2020, 15 (1): 1–6;

Abstract ( 434 ) PDF (804KB) ( 523 )

Compulsory Licensing of Pharmaceutical Patents System from the Perspective of Public Interest-Public Health in China

Zhang Yubo, Yuan Hongmei

2020, 15 (1): 7–15;

Abstract ( 627 ) PDF (757KB) ( 488 )

Application Research of Earned Value Management in New Drug Research and Development Projects

Wang Wanting, Xing Hua

2020, 15 (1): 16–21;

Abstract ( 477 ) PDF (732KB) ( 598 )

Pharmacoeconomic Evaluation of Rituximab (Hanlikang) for Patients with Rheumatoid Arthritis

Wang Yanqi, Chen Binbin, Zhao Mengmeng, Sun Lihua

2020, 15 (1): 22–29;

Abstract ( 492 ) PDF (1014KB) ( 491 )

Research on the Transformation of Mapping Method for Cancer Patients’ Health Utility in the Asia-Pacific Region

Zhang Jie, Sun Quan, Zhang Fang

2020, 15 (1): 30–36;

Abstract ( 498 ) PDF (1007KB) ( 469 )

The Analysis of Marketing Strategy of Plendil

Fu Geyang, Tian Lijuan

2020, 15 (1): 37–43;

Abstract ( 649 ) PDF (749KB) ( 982 )

Comparative Study on the Development of Urban Basic Medical Insurance in 14 Cities of Liaoning Province

Zhi Yuanyuan, Wang Shuling

2020, 15 (1): 44–56;

Abstract ( 468 ) PDF (1963KB) ( 509 )